We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

AZT (Zidovudine) Just a Step Away From FDA Approval for AIDS Therapy

Charles Marwick
JAMA. 1987;257(10):1281-1282. doi:10.1001/jama.1987.03390100015002.
Text Size: A A A
Published online


AN ADVISORY COMMITTEE of the Food and Drug Administration (FDA), by a vote of ten to one, has recommended that the FDA commissioner approve the anti-viral drug azidothymidine (AZT) for the treatment of acquired immunodeficiency syndrome (AIDS).

The United States Adopted Name (USAN) designation for AZT, decided upon earlier this year, is zidovudine.

The drug has been shown to inhibit the enzyme that the AIDS virus uses to replicate in the cell. It also appears to have other advantages in the management of patients with AIDS, such as the ability to penetrate the blood-brain barrier.

The committee's action is not binding on the agency, but such advice always carries considerable weight. Given the present poor outlook for patients with AIDS and the lack of effective treatment for the disease, the agency is unlikely to reject the committee's recommendation.

Yet, even when approved, AZT will be restricted to those groups of


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...